Charles River Laboratories International is a full service, non-clinical global drug development partner. Co. has laboratory animal medicine and science (research model technologies) to develop a portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, that supports its clients from target identification through non-clinical development. Co. also provides a suite of products and services to support its clients' manufacturing activities, including its contract development and manufacturing organization business. Co. has three reporting segments: Research Models and Services, Discovery and Safety Assessment and Manufacturing Solutions. The CRL YTD return is shown above.
The YTD Return on the CRL YTD return page and across the coverage universe of our site,
is a measure of the total return for a given investment year-to-date for the current calendar year
(up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement
period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely
useful in the context of our country's tax system which taxes gains and income on a calendar year basis.
Thus, researching Year-To-Date Returns is good practice for investors — whether CRL YTD return or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the CRL YTD return calculation (with any dividends reinvested as applicable), and to provide a
coverage universe of many stocks and ETFs to be able to compare YTD returns.
|